CSIMarket
 


Patterson Companies Inc   (PDCO)
Other Ticker:  
 

Patterson Companies Inc 's Leverage Ratio

PDCO's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to net new borrowings of 7.21%, Leverage Ratio fell to 1.94, above the Patterson Companies Inc 's average Leverage Ratio.

Within Medical Equipment & Supplies industry in the third quarter 2023, 79 other companies have achieved lower Leverage Ratio than Patterson Companies Inc in the III Quarter 2023. While Leverage Ratio total ranking has improved so far in the third quarter 2023 to 1392, from total ranking in the second quarter 2023 at 2414 .

Explain Leverage Ratio?
Who are PDCO Customers?
What are PDCO´s Total Liabilities?


PDCO Leverage Ratio (Jan 27 2024)
III. Quarter
(Oct 28 2023)
II. Quarter
(Jul 29 2023)
I. Quarter
(Apr 29 2023)
IV. Quarter
(Jan 28 2023)
III. Quarter
Y / Y Equity Change -11.82 % 1.25 % 8.2 % 7.28 % 5.58 %
Y / Y Total Liabilities Change 5.37 % -1.71 % 2.71 % 5.45 % 2.6 %
Leverage Ratio MRQ 1.94 1.67 1.53 1.57 1.63
PDCO's Total Ranking # 1392 # 2414 # 2373 # 2422 # 2566
Seq. Equity Change -7.86 % -5.05 % -0.65 % 1.46 % 5.79 %
Seq. Total Liabilities Change 7.21 % 3.53 % -3.45 % -1.68 % 0.01 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 80
Healthcare Sector # 270
Overall Market # 1392


Leverage Ratio Statistics
High Average Low
2.21 1.13 0.37
(Apr 25 2020)   (Oct. 29, 2007)




Financial Statements
Patterson Companies Inc 's Equity $ 972 Millions Visit PDCO's Balance sheet
Patterson Companies Inc 's Total Liabilities $ 1,888 Millions Visit PDCO's Balance sheet
Source of PDCO's Sales Visit PDCO's Sales by Geography


Cumulative Patterson Companies Inc 's Leverage Ratio

PDCO's Leverage Ratio for the trailling 12 Months

PDCO Leverage Ratio

(Jan 27 2024)
III. Quarter
(Oct 28 2023)
II. Quarter
(Jul 29 2023)
I. Quarter
(Apr 29 2023)
IV. Quarter
(Jan 28 2023)
III. Quarter
Y / Y Equity TTM Growth -11.82 % 1.25 % 8.2 % 7.28 % 5.58 %
Y / Y Total Liabilities TTM Growth 5.37 % -1.71 % 2.71 % 5.45 % 2.6 %
Leverage Ratio TTM 1.67 1.6 1.61 1.63 1.64
Total Ranking TTM # 1143 # 2337 # 10 # 10 # 117
Seq. Equity TTM Growth -7.86 % -5.05 % -0.65 % 1.46 % 5.79 %
Seq. Total Liabilities TTM Growth 7.21 % 3.53 % -3.45 % -1.68 % 0.01 %


On the trailing twelve months basis Due to the net new borrowings of 7.21% during the trailing twelve months finishing in the III Quarter 2023, cumulativeLeverage Ratio improved to 1.67, above the Patterson Companies Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 71, during the past 12 months, other companies have achieved lower Leverage Ratio than Patterson Companies Inc . While Leverage Ratio total ranking has improved so far to 1143, from total ranking in previous 12 month period at 2337.

Explain Leverage Ratio?
Who are PDCO Customers?
What are PDCO´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 72
Healthcare Sector # 215
Within the Market # 1143


trailing twelve months Leverage Ratio Statistics
High Average Low
2.13 1.13 0.4
(Jan 23 2021)   (Oct. 29, 2007)




Companies with similar Leverage Ratio in the quarter ending Jan 27 2024, within Medical Equipment & Supplies Industry Leverage RatioJan 27 2024 MRQ Total LiabilitiesJan 27 2024 MRQ Equity
Owens and Minor inc  4.23 $ 3,905.075  Millions$ 924.166  Millions
Petvivo Holdings Inc  3.06 $ 2.735  Millions$ 0.895  Millions
Bioventus Inc   2.88 $ 637.319  Millions$ 221.118  Millions
The Pennant Group Inc   2.74 $ 399.352  Millions$ 145.515  Millions
Insulet Corporation  2.53 $ 1,855.500  Millions$ 732.700  Millions
Baxter International Inc   2.35 $ 19,874.000  Millions$ 8,468.000  Millions
Neuronetics inc   2.29 $ 78.450  Millions$ 34.190  Millions
Nuwellis Inc   2.27 $ 6.780  Millions$ 2.990  Millions
Dexcom Inc   1.97 $ 4,076.300  Millions$ 2,068.600  Millions
Patterson Companies Inc   1.94 $ 1,887.968  Millions$ 972.165  Millions
Novocure Limited  1.93 $ 698.909  Millions$ 362.496  Millions
Zynex inc   1.88 $ 86.850  Millions$ 46.129  Millions
Tandem Diabetes Care Inc   1.84 $ 577.972  Millions$ 313.632  Millions
Artivion Inc   1.81 $ 510.617  Millions$ 281.780  Millions
Intelligent Bio Solutions Inc   1.76 $ 5.547  Millions$ 3.154  Millions
Conmed Corporation  1.68 $ 1,404.897  Millions$ 834.222  Millions
Stereotaxis Inc   1.56 $ 25.566  Millions$ 16.343  Millions
Escalon Medical Corp   1.56 $ 2.869  Millions$ 1.837  Millions
Henry Schein Inc  1.36 $ 5,840.000  Millions$ 4,289.000  Millions
Shockwave Medical Inc   1.34 $ 897.886  Millions$ 668.677  Millions
Beyond Air Inc   1.32 $ 31.097  Millions$ 23.471  Millions
Cytosorbents Corporation  1.29 $ 29.985  Millions$ 23.275  Millions
Msa Safety Incorporated  1.24 $ 1,203.348  Millions$ 966.802  Millions
Masimo Corp  1.23 $ 1,676.700  Millions$ 1,364.800  Millions
Cadre Holdings Inc   1.19 $ 234.017  Millions$ 197.162  Millions
Haemonetics Corporation  1.19 $ 1,118.604  Millions$ 943.319  Millions
Integra Lifesciences Holdings Corp  1.18 $ 1,878.914  Millions$ 1,587.884  Millions
Quoin Pharmaceuticals Ltd   1.15 $ 6.505  Millions$ 5.664  Millions
Electrocore Inc   1.08 $ 8.034  Millions$ 7.442  Millions
Adm Tronics Unlimited Inc   1.06 $ 1.168  Millions$ 1.103  Millions

Date modified: 2024-02-29T18:52:28+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com